当前位置: X-MOL 学术J. Mater. Chem. B › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy
Journal of Materials Chemistry B ( IF 7 ) Pub Date : 2017-11-07 00:00:00 , DOI: 10.1039/c7tb90158e
Dayeon Yun 1, 2, 3, 4 , Hyun-Ouk Kim 1, 2, 3, 4 , Hye Young Son 2, 4, 5, 6 , Yuna Choi 2, 4, 5, 6 , Ilkoo Noh 1, 4, 7, 8 , Jong-Woo Lim 1, 2, 3, 4 , Jihye Kim 1, 2, 3, 4 , Haejin Chun 1, 2, 3, 4 , Geunseon Park 1, 2, 3, 4 , Dong Ki Lee 4, 9, 10, 11, 12 , Sung Il Jang 4, 9, 10, 11, 12 , Eunji Jang 2, 4, 5, 6 , Yong-Min Huh 2, 4, 5, 6 , Seungjoo Haam 1, 2, 3, 4
Affiliation  

Correction for ‘Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy’ by Dayeon Yun et al., J. Mater. Chem. B, 2017, 5, 6317–6324.

中文翻译:

更正:包含靶向CD44的聚合物前药纳米颗粒的支架,该纳米颗粒以时间间隔可控的方式释放紫杉醇和吉西他滨,用于人类胆道癌的协同治疗。

Dayeon Yun等人对“含有CD44的聚合物前药纳米颗粒的支架进行了校正,该纳米颗粒以时间间隔可控的方式释放紫杉醇和吉西他滨用于协同性人类胆道癌治疗” J。Mater。化学 乙,2017年,5,6317-6324。
更新日期:2017-11-15
down
wechat
bug